AI
Saturday, December 29, 2007 9:09:08 AM
to sterling, revised figures look o.k. imho. when asked you always there with good honest response.
except for share count pps evaluation is on track.
old excerpt for evaluation: 12/25/07 see message #msg-25540961
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Their MEDLIGHT(TM) 630PRO is a product that is developed by NASA. NASA wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the Outstanding Shares (OS) in the IBox is correct as 4,820,000,000 Shares as of 11 Jul 07, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 4,820,000,000 Shares = EPS
.00019 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x .00019 = .0023 Current Share Price
(That’s just from the above contract alone.)
This is a conservative price for YNGR as I think that if they reveal more contracts, they reveal more value for their company that I trust that CEC would definitely have a vested interest in making sure the investing community fully understands the magnitude. I hope this helps.
Happy Holidays to All!
v/r
Sterling
-------------------------------------------------------------
revised evaluation 12/29/07
YNGR Valuation (Revisions #1, 2, & 3)…
Before reading the “3” YNGR Valuation Revisions, I think it’s first important to understand a little about their product that they are offering to the public to know that they do have something that is very real.
** The MEDLIGHT 630 PRO has received UL Certification.
** The MEDLIGHT 630 PRO is cleared by the FDA for over the counter sales without a prescription for the temporary relief of pain.
** The MEDLIGHT 630 PRO utilizes NASA developed LED technology.
http://www.yourlifewithoutpain.com/
http://www.jrsmedical.com/PAIN_MANAGEMENT/MD630PRO/product.aspx
(This is the logo YNGR uses to reflect what I mentioned above.)
[*chart]www.fotothing.com/photos/us/7134.jpg[*/chart]
Now that we know that we are dealing with a very real product, let’s further analyze. The link below reflects the ”original version” of the YNGR valuation to consider as a framework for trying to assess the valuation of YNGR from one of their recent contracts which reflected a .0023 per share valuation considering if the Outstanding Shares (OS) was 4,820,000,000 Shares, but had to be revised:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=25540961
Below are Revisions #1, 2, & 3 from using the framework of the original version for considering…
#1 … if the OS was maxed out to be what was reflected at the Nevada Secretary of State as the Authorized Shares (AS).
#2 … if the OS was maxed out to be what was reflected by the Transfer Agent (TA) as the Authorized Shares (AS).
#3 … considering what the company released in a PR back on 5 Sep 07.
Let’s first rehash a couple of key points for a memory refresher.
The good news with YNGR is that they have released Big Apple and has retained the Investor Relations services of Competitive Edge Consultants, Inc. (CEC) for its Investor Relations needs.
The beauty of this is the huge show of confidence in where Dale Semler of CEC stated where they believe they will get YNGR to when stating… “There are very few opportunities that exist in the marketplace for our firm to represent a company whose net assets appear to be far greater than is currently realized. We are very excited about this opportunity and have agreed to an incentive-based contract with Younger America based on the number of new investors that we bring to the company. We are always available to talk to the investment community about Younger America Corporation and look forward to speaking with current shareholders.”
http://biz.yahoo.com/iw/071220/0342391.html
This means the higher CEC gets the price of YNGR, the more money they will get paid for services rendered. This is a very serious incentive clause in my opinion. They know something big about the company and what they can do that we all don’t know yet. To agree to an incentive-based contract to be based upon the amount of investors they bring in is a huge subliminal message to me.
Below are “3” different YNGR Valuation Revisions to consider for YNGR:
YNGR Valuation Revision #1:
On 14 Nov 07, YNGR released a PR stating that YNGR signed a contract with an Ohio Chiropractor to distribute 25,000 MEDLIGHT(TM) 630PRO Units:
http://biz.yahoo.com/iw/071114/0328279.html
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the OS has been maxed out to the 10 Billion shares that are reflected at the Nevada Secretary of State, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 10,000,000,000 Shares = EPS
0.0000937188 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0000937188 = 0.0011 Current Share Price Value
(That’s just from the above contract alone.)
YNGR Valuation Revision #2:
On 14 Nov 07, YNGR released a PR stating that YNGR signed a contract with an Ohio Chiropractor to distribute 25,000 MEDLIGHT(TM) 630PRO Units:
http://biz.yahoo.com/iw/071114/0328279.html
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the OS has been maxed out to the 20 Billion shares that are reflected at their TA, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 20,000,000,000 Shares = EPS
0.0000468594 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0000468594 = 0.00056 Current Share Price Value
(That’s just from the above contract alone.)
YNGR Valuation Revision #3:
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too.
Now with the PR below from YNGR, we can keep this fairly simple.
http://biz.yahoo.com/iw/070905/0297813.html
The PR stated that YNGR is expected to have $4 million in net worth. Net worth is your figure known as Earnings or Income as it is the bottom line amount of Profit after taking under consideration Expenses. So, with a worse case scenario with maxing out the OS to be 20 Billion, we would have what’s reflected below for YNGR potential as for what the company believes:
Income ÷ OS = EPS
$4,000,000 ÷ 20,000,000,000 Shares = EPS
0.0002 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0002 = 0.0024 Current Share Price Value
So, currently, YNGR could be considered to be trading at less than 24 times its current value as a worse case scenario. I think .0001 per share is a fair price given its “potential” for growth from doing my DD. I recommend everyone to please do their own DD as those feeling different will have my respect for such. No matter how you crumble up the cookie or cut the piece of cake, YNGR is still undervalued at .0001 per share and is very solid in my opinion at these levels.
Happy Holidays to All!
v/r
Sterling
except for share count pps evaluation is on track.
old excerpt for evaluation: 12/25/07 see message #msg-25540961
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Their MEDLIGHT(TM) 630PRO is a product that is developed by NASA. NASA wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the Outstanding Shares (OS) in the IBox is correct as 4,820,000,000 Shares as of 11 Jul 07, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 4,820,000,000 Shares = EPS
.00019 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x .00019 = .0023 Current Share Price
(That’s just from the above contract alone.)
This is a conservative price for YNGR as I think that if they reveal more contracts, they reveal more value for their company that I trust that CEC would definitely have a vested interest in making sure the investing community fully understands the magnitude. I hope this helps.
Happy Holidays to All!
v/r
Sterling
-------------------------------------------------------------
revised evaluation 12/29/07
YNGR Valuation (Revisions #1, 2, & 3)…
Before reading the “3” YNGR Valuation Revisions, I think it’s first important to understand a little about their product that they are offering to the public to know that they do have something that is very real.
** The MEDLIGHT 630 PRO has received UL Certification.
** The MEDLIGHT 630 PRO is cleared by the FDA for over the counter sales without a prescription for the temporary relief of pain.
** The MEDLIGHT 630 PRO utilizes NASA developed LED technology.
http://www.yourlifewithoutpain.com/
http://www.jrsmedical.com/PAIN_MANAGEMENT/MD630PRO/product.aspx
(This is the logo YNGR uses to reflect what I mentioned above.)
[*chart]www.fotothing.com/photos/us/7134.jpg[*/chart]
Now that we know that we are dealing with a very real product, let’s further analyze. The link below reflects the ”original version” of the YNGR valuation to consider as a framework for trying to assess the valuation of YNGR from one of their recent contracts which reflected a .0023 per share valuation considering if the Outstanding Shares (OS) was 4,820,000,000 Shares, but had to be revised:
http://investorshub.advfn.com/boards/read_msg.asp?message_id=25540961
Below are Revisions #1, 2, & 3 from using the framework of the original version for considering…
#1 … if the OS was maxed out to be what was reflected at the Nevada Secretary of State as the Authorized Shares (AS).
#2 … if the OS was maxed out to be what was reflected by the Transfer Agent (TA) as the Authorized Shares (AS).
#3 … considering what the company released in a PR back on 5 Sep 07.
Let’s first rehash a couple of key points for a memory refresher.
The good news with YNGR is that they have released Big Apple and has retained the Investor Relations services of Competitive Edge Consultants, Inc. (CEC) for its Investor Relations needs.
The beauty of this is the huge show of confidence in where Dale Semler of CEC stated where they believe they will get YNGR to when stating… “There are very few opportunities that exist in the marketplace for our firm to represent a company whose net assets appear to be far greater than is currently realized. We are very excited about this opportunity and have agreed to an incentive-based contract with Younger America based on the number of new investors that we bring to the company. We are always available to talk to the investment community about Younger America Corporation and look forward to speaking with current shareholders.”
http://biz.yahoo.com/iw/071220/0342391.html
This means the higher CEC gets the price of YNGR, the more money they will get paid for services rendered. This is a very serious incentive clause in my opinion. They know something big about the company and what they can do that we all don’t know yet. To agree to an incentive-based contract to be based upon the amount of investors they bring in is a huge subliminal message to me.
Below are “3” different YNGR Valuation Revisions to consider for YNGR:
YNGR Valuation Revision #1:
On 14 Nov 07, YNGR released a PR stating that YNGR signed a contract with an Ohio Chiropractor to distribute 25,000 MEDLIGHT(TM) 630PRO Units:
http://biz.yahoo.com/iw/071114/0328279.html
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the OS has been maxed out to the 10 Billion shares that are reflected at the Nevada Secretary of State, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 10,000,000,000 Shares = EPS
0.0000937188 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0000937188 = 0.0011 Current Share Price Value
(That’s just from the above contract alone.)
YNGR Valuation Revision #2:
On 14 Nov 07, YNGR released a PR stating that YNGR signed a contract with an Ohio Chiropractor to distribute 25,000 MEDLIGHT(TM) 630PRO Units:
http://biz.yahoo.com/iw/071114/0328279.html
From the company’s website below, the MEDLIGHT(TM) 630PRO Units cost $149.95 per unit:
https://www.yourlifewithoutpain.com/osc/
25,000 x $149.95 = $3,748,750 in Revenues
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too. Still, I will give it a basic 25% Profit Margin to reflect the amount below as Income:
$3,748,750 in Revenues x .25 = $937,188 as Income
Considering that the OS has been maxed out to the 20 Billion shares that are reflected at their TA, then we could derive an Earnings Per Share (EPS) to derive a valuation below just from that “1” contract to not include others:
Income ÷ OS = EPS
$937,188 ÷ 20,000,000,000 Shares = EPS
0.0000468594 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0000468594 = 0.00056 Current Share Price Value
(That’s just from the above contract alone.)
YNGR Valuation Revision #3:
Again, their MEDLIGHT(TM) 630PRO is a product that is developed by NASA, cleared by the FDA, and has received UL Certification. NASA, the FDA, and the UL wouldn’t be bothered with just anybody. This is also huge to me too.
Now with the PR below from YNGR, we can keep this fairly simple.
http://biz.yahoo.com/iw/070905/0297813.html
The PR stated that YNGR is expected to have $4 million in net worth. Net worth is your figure known as Earnings or Income as it is the bottom line amount of Profit after taking under consideration Expenses. So, with a worse case scenario with maxing out the OS to be 20 Billion, we would have what’s reflected below for YNGR potential as for what the company believes:
Income ÷ OS = EPS
$4,000,000 ÷ 20,000,000,000 Shares = EPS
0.0002 = EPS
With using a conservative 12 PE Ratio, consider below for a share price valuation:
12 PE Ratio x 0.0002 = 0.0024 Current Share Price Value
So, currently, YNGR could be considered to be trading at less than 24 times its current value as a worse case scenario. I think .0001 per share is a fair price given its “potential” for growth from doing my DD. I recommend everyone to please do their own DD as those feeling different will have my respect for such. No matter how you crumble up the cookie or cut the piece of cake, YNGR is still undervalued at .0001 per share and is very solid in my opinion at these levels.
Happy Holidays to All!
v/r
Sterling
Caspermick
"TOUGH TIMES NEVER LAST BUT TOUGH PEOPLE DO."
God Bless America
In Gambling,,,Playing Card Games. Ya Never Know What The Next Hand Will Look Like.
Ten Bagger Potential Stock
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
